 |
|
Effect of Medicare Coverage on Use of Invasive Colorectal Cancer Screening Tests
Cynthia W. Ko, MD,MS;
William Kreuter, MPA;
Laura-Mae Baldwin, MD,MPH
Arch Intern Med. 2002;162:2581-2586.
Background Colorectal cancer is the second leading cause of cancer death in the United States. Screening for colorectal cancer is now widely recommended but underused. Lack of insurance coverage for screening tests may be one reason patients do not undergo these procedures.
Objective To determine the effect of Medicare reimbursement on utilization rates of invasive screening tests. Use of fecal occult blood testing was not studied before 1998.
Methods We performed a retrospective analysis of ambulatory claims data for Washington State Medicare beneficiaries in 1994, 1995, and 1998. We determined the proportion of patients undergoing diagnostic and screening flexible sigmoidoscopy, colonoscopy, or double-contrast barium enema in 1994, 1995, and 1998 and the proportion receiving fecal occult blood testing in 1998.
Results Use of diagnostic and screening colon tests was low in all years. Fewer than 6% of beneficiaries received any colon test, and fewer than 4% received a screening test. Although more patients underwent diagnostic testing after Medicare coverage began, use of screening tests did not significantly change (odds ratio, 0.99; 95% confidence interval, 0.97-1.01 comparing 1994 and 1998 [P = .33]). Women, individuals older than 80 years, and nonwhite patients were statistically significantly less likely to be screened in all 3 years (P<.001). In 1998, fewer than 7% of patients underwent fecal occult blood testing, with men and nonwhites statistically significantly less likely to have this test (P<.001).
Conclusions Colorectal cancer screening tests are underused in the Washington State Medicare population, and insurance coverage for these tests did not substantially affect utilization rates in the period studied.
From the Departments of Medicine (Dr Ko and Mr Kreuter) and Family Medicine (Dr Baldwin), University of Washington, Seattle. The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Data Sources for Measuring Colorectal Endoscopy Use Among Medicare Enrollees
Schenck et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2118-2127.
ABSTRACT
| FULL TEXT
Relation Between Medicare Screening Reimbursement and Stage at Diagnosis for Older Patients With Colon Cancer
Gross et al.
JAMA 2006;296:2815-2822.
ABSTRACT
| FULL TEXT
The use of screening colonoscopy for patients cared for by the department of veterans affairs.
El-Serag et al.
Arch Intern Med 2006;166:2202-2208.
ABSTRACT
| FULL TEXT
Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly?
Shih et al.
Health Aff (Millwood) 2006;25:1153-1162.
ABSTRACT
| FULL TEXT
Disparities Despite Coverage: Gaps in Colorectal Cancer Screening Among Medicare Beneficiaries
O'Malley et al.
Arch Intern Med 2005;165:2129-2135.
ABSTRACT
| FULL TEXT
Enrollment of Older Persons in Cancer Trials After the Medicare Reimbursement Policy Change
Gross et al.
Arch Intern Med 2005;165:1514-1520.
ABSTRACT
| FULL TEXT
Age-Related Disparities in Cancer Screening: Analysis of 2001 Behavioral Risk Factor Surveillance System Data
Jerant et al.
Ann Fam Med 2004;2:481-487.
ABSTRACT
| FULL TEXT
|
